BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


BATM Shares Jump 20% As Develops Diagnostic Kit To Detect Coronavirus


UK Earnings, Trading Statements Calendar - Next 7 Days


BATM Wins USD4 Million Order From Existing Government Defence Customer


BATM Wins USD1.3 Million Contract For Agri-Waste Treatment Solution


(Sharecast News) - Networking solutions and medical laboratory systems provider BATM Advanced Communications announced on Tuesday that Ador Diagnostic...


BATM Unit Gets First Commercial Order For Meningitis Test


(Sharecast News) - BATM Advanced Communications has been awarded a $4m contract by a Taiwanese agri-food conglomerate for its agri-waste treatment sol...


BATM Advanced Communications Secures USD4 Million Contract In Taiwan